ORLAND MATA: Open Payments
NPI 1235688441 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 21 payments from 12 companies in 2025. Trend: 2023 $280 · 2024 $142 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 5 | $106 |
| Novo Nordisk Inc | 5 | $105 |
| Abbott Laboratories | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 1 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
| Amgen Inc. | 1 | $20 |
Products named: Korlym, Ozempic, Wegovy, FREESTYLE LIBRE, AUSTEDO XR, FANAPT, CAPLYTA, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
